Seven Eight Capital, LP Liva Nova PLC Transaction History

Seven Eight Capital, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$43.45 - $53.66 $796,786 - $984,017	18,338 New	18,338 $948,000
Q2 2021 Aug 13, 2021	SELL	$73.44 - $87.01 $421,765 - $499,698	-5,743 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$46.01 - $68.74 $795,973 - $1.19 Million	-17,300 Reduced 75.08%	5,743 $380,000
Q3 2020 Nov 16, 2020	BUY	$41.91 - $57.81 $965,732 - $1.33 Million	23,043 New	23,043 $1.04 Million
Q2 2020 Aug 06, 2020	SELL	$39.87 - $56.9 $350,856 - $500,720	-8,800 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$34.22 - $76.49 $301,136 - $673,112	8,800 New	8,800 $398,000
Q3 2019 Nov 14, 2019	SELL	$71.74 - $86.35 $2.62 Million - $3.15 Million	-36,526 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$66.45 - $97.36 $2.43 Million - $3.56 Million	36,526 New	36,526 $2.63 Million
Q4 2018 Feb 14, 2019	SELL	$84.14 - $125.42 $3.26 Million - $4.87 Million	-38,800 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$101.02 - $130.95 $3.92 Million - $5.08 Million	38,800 New	38,800 $4.81 Million
Q1 2018 May 14, 2018	SELL	$79.95 - $89.74 $207,870 - $233,324	-2,600 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$71.8 - $88.21 $186,680 - $229,345	2,600	2,600 $208,000

264

53M

316K

127K

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.61B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.